5th Webinar on

Antibiotics

February 18, 2022

Antibiotic Webinar

Theme: New Antibiotic Researches to Fight Resistance

A webinar on Antibiotics is going to be hosted on February 18th, 2022. This webinar aims to support global researchers and students in delivering their ideas through a secure and successful event. The main objective of Antibiotics 2022 is, “New Antibiotic Researches to Fight Resistance". This will provide a platform to discuss and exchange innovative ideas and to share research experiences with young aspirants in various fields of Antibiotics.

Session 01:- Genetics of Antimicrobial Resistance
Antibiotic Resistance acquired by bacteria can be achieved through gene mutation or the acquisition of foreign resistance genes or a combined mechanism. The session is open for most common resistance mechanisms employed by bacteria, alteration of the antimicrobial, performing/introducing a mutation in the antimicrobial target site, active efflux of the antimicrobial across the cell membrane, types of antibiotic resistance, about horizontal gene transfer, molecular genetic work.
Antibiotics Conference | Antibiotic Workshops | Antibiotic Resistance Conference | Multidrug Resistance Conference | Next Generation Antibiotic Conference | Antibiotic Symposiums | Antibiotic World Congress | Antibiotic therapy Workshops
Session 02:- Antibiotic Therapy
Certain antibiotics are effective against protozoans and fungi; toxicity is observed, even when the therapeutic dosage is administered in humans and animals. Viral antigens are resistant to antibiotics such as the common cold, influenza, and the present coronavirus and may be harmful when taken inappropriately. Antibiotic misuse has been observed as a concern in the medical community. Many general principles can help you make decisions about initiating, selecting, and discontinuing antibiotic therapy. The therapies include; Outpatient therapy: This treatment lasts for about 28 to 90 days, depending upon what you are expecting from the treatment. Hospital therapy: Empirical administration of antibiotics as the first line of treatment of broader specificity.
Antibiotics Conference | Antibiotic Workshops | Antibiotic Resistance Conference | Multidrug Resistance Conference | Next-generation Antibiotic Conference | Antibiotic Symposiums | Antibiotic World Congress | Antibiotic therapy Workshops | Antibiotic Resistance Symposiums
Session 03:- Antibiotics in Oncology
For patients getting chemotherapy, there is an expanded danger of disease because of a low WBC tally (neutropenia) caused by a dangerous impact of chemotherapy on the bone marrow. The most critical diminishment in mortality was seen in surveying prophylaxis with quinolones. For patients with hematologic tumors, anti-microbial prophylaxis is emphatically prescribed, ideally with a quinolone. Prophylaxis may likewise be considered for patients with strong tumors or lymphoma
Antibiotics Conference | Antibiotic Workshops | Antibiotic Resistance Conference | Multidrug Resistance Conference | Next Generation Antibiotic Conference | Antibiotic Symposiums | Antibiotic World Congress | Antibiotic therapy Workshops | Antibiotic Resistance Symposiums
Session 04:- Antibiotic Resistance & Prevention
Antibiotic resistance has emerged as an important determinant of outcomes for patients in the intensive care unit (ICU). This is mostly due to the administration of inadequate antimicrobial treatment, which is most repeatedly related to bacterial antibiotic resistance. World Health Organization (WHO) classified Antibiotic resistance as a hazard, wherein the situation could turn pathetic in the future. Antibiotic resistance has spread across the world regardless of age and turned out to be a challenge for medical research. First-line treatment though broader, hasn’t been effective. Bacteria have become resistant to antimicrobial agents as a result of chromosomal changes or the exchange of genetic material via a plasmid. Streptococcus pneumonia, Streptococcus pyogenic, and staphylococci, organisms are now resistant to all of the older antibiotics
Antibiotics Conference | Antibiotic Workshops | Antibiotic Resistance Conference | Multidrug Resistance Conference | Next-generation Antibiotic Conference | Antibiotic Symposiums | Antibiotic World Congress | Antibiotic therapy workshops | Antibiotic Resistance Symposiums
Session 05:- Clinical Trials of Antibiotics
Clinical trials in the initial stages are being carried out extensively to at least reach the primary stage of establishing the drug safety, efficacy by pharmaceutical companies to persuade the regulatory body. But the results obtained haven’t shown a promising quality. Though the use of antibiotics is widespread in the medical field, drug safety is a matter
Antibiotics Conference | Antibiotic Workshops | Antibiotic Resistance Conference | Multidrug Resistance Conference | Next-generation Antibiotic Conference | Antibiotic Symposiums | Antibiotic World Congress | Antibiotic therapy Workshops | Antibiotic Resistance Symposiums

  • Genetics of Antimicrobial Resistance
  • Antibiotic Therapy
  • Antibiotics in Oncology
  • Antibiotic Resistance & Prevention
  • Clinical Trials of Antibiotics